OptimizeRx Corporation
OPRX
$12.89
$0.393.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 68.13% | 98.12% | -218.46% | 3.65% | -7.83% |
| Total Depreciation and Amortization | 0.70% | 25.62% | 139.95% | 139.95% | 139.42% |
| Total Amortization of Deferred Charges | 4.74% | -19.12% | 470.83% | 438.30% | 427.08% |
| Total Other Non-Cash Items | -50.63% | -62.05% | 145.78% | -19.70% | -30.01% |
| Change in Net Operating Assets | -29.81% | 61.77% | 174.24% | 127.68% | 244.44% |
| Cash from Operations | 82.44% | 103.16% | 21.59% | 133.01% | 2,562.79% |
| Capital Expenditure | 15.63% | -240.00% | 45.45% | -125.00% | -10.34% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 52.89% | -100.19% | 92.43% | -101.23% | 92.04% |
| Cash from Investing | 45.10% | 99.54% | 90.89% | -102.64% | 90.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -46.20% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 37.86% | -121.92% | 34.69% | 94.54% | 18.13% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 8.28% | -107.80% | -52.87% | 87.78% | -388.55% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 140.98% | -169.89% | 906.03% | 96.71% | 174.99% |